Published by Benjamin Chiou on 17th September 2024
(Sharecast News) - Japan's health ministry has accepted for review a new drug application (NDA) for GSK's Blenrep blood cancer treatment, marking the third major regulatory filing acceptance for the drug.
URL: http://www.digitallook.com/dl/news/story/34559350/...